albiglutide
110932
Phase 2 mab completed
Quick answer
albiglutide for Diabetes Mellitus, Type 2 is a Phase 2 program (mab) at GlaxoSmithKline with 1 ClinicalTrials.gov record(s).
Program details
- Company
- GlaxoSmithKline
- Indication
- Diabetes Mellitus, Type 2
- Phase
- Phase 2
- Modality
- mab
- Status
- completed